RE:RE:KSW thanks for that comprehensive analysis but
canadafan wrote: Yes, Im curious to see a N.R. out of the presentaions today.
The tweet postd on a big enough screen does reveal positive reaction/
"pela pimes the immune system"
Not sure why no N.R. ?
Ahe A.N. abstract seems to be a wild card.
Regarding the SP & potential buyout.
The value of ONC as a buyout has absoutly zero to do with trading share price.
It has the do with the "present value of potential forward income"
Meaning what can ONC/Pela bring to the table for an aquiring company.
Many many private companies are bought out with essentially zero share trading value
ONC(Y) just so happens to be public traded & manipulated by day trades & shortsellers.
Check out this link on "explaining Biotech valuation"
Notice..not once does it mention trading shareprice value.
An aquiring pharma would be buying the potential opportunity/income from Pela sales.
https://www.investopedia.com/articles/stocks/06/biotechvaluation.asp#:~:text=Portfolio%20Valuation%20Approach,-Think%20of%20a&text=In%20other%20words%2C%20you%20determine,whole%20company%20is%20worth%20today.
I am in total agreement, that is why I generally state 'STOP killing yourselves over daily SP', daily SP just does not matter when ONC/ONCY is evaluated for revenue steams but a buyer, which forecasted revenues and only forecasted revenues will drive the buyout price.
The daily market cap means absolutely nothing. It does no need to climb for a better offer as some suggest here. It is irrelavant. I totally agree in this application.